Literature DB >> 10563648

Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course.

A Svenningsson1, A S Petersson, O Andersen, G K Hansson.   

Abstract

In this study, we have analyzed the stable metabolites of nitric oxide (NO), nitrite and nitrate, in the CSF of patients with MS, lymphocytic meningitis, and in healthy control subjects. Patients with MS with an active disease course exhibited increased CSF nitrite levels compared with patients with stable MS and healthy control subjects, whereas CSF nitrate levels did not differ between these groups. High CSF levels of both metabolites were seen in patients with meningitis. These data indicate that CSF nitrite levels may reflect clinical disease activity in MS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563648     DOI: 10.1212/wnl.53.8.1880

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis.

Authors:  K Rejdak; A Petzold; T Kocki; J Kurzepa; P Grieb; W A Turski; Z Stelmasiak
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

2.  Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  Anne I Boullerne; Jose J Rodriguez; Tarik Touil; Bruno Brochet; Stephan Schmidt; Nora D Abrous; Michel Le Moal; Jeffrey R Pua; Mark A Jensen; Willy Mayo; Barry G W Arnason; Klaus G Petry
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 3.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Heather A Bixler; Andrzej Pastuszyn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

5.  Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.

Authors:  Gurudutt Pendyala; Howard S Fox
Journal:  Genome Med       Date:  2010-03-30       Impact factor: 11.117

Review 6.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

7.  Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.

Authors:  William R Wikoff; Gurudutt Pendyala; Gary Siuzdak; Howard S Fox
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

8.  Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.

Authors:  Carlo Selmi; Anna Maria Papini; Piera Pugliese; Maria Claudia Alcaro; M Eric Gershwin
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

Review 9.  Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.

Authors:  Cullen O'Gorman; Robyn Lucas; Bruce Taylor
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

Review 10.  Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis.

Authors:  Moritz Förster; Christopher Nelke; Saskia Räuber; Hans Lassmann; Tobias Ruck; Maria Pia Sormani; Alessio Signori; Hans-Peter Hartung; Patrick Küry; Sven G Meuth; David Kremer
Journal:  Biomedicines       Date:  2021-12-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.